MedPath

Post-Surgery Extracorporeal Life Support

Recruiting
Conditions
Post Cardiac Arrest Syndrome
Cardiogenic Shock
Post-cardiac Surgery
Extracorporeal Membrane Oxygenation Complication
Extracorporeal Life Support
Registration Number
NCT04330651
Lead Sponsor
University of Florence
Brief Summary

Extracorporeal Life Support (ECLS) may provide pulmonary and circulatory support for patients with acute heart failure refractory to conventional medical therapy. However, indications and effectiveness of ECLS engagement post-surgery remains a concern. The investigators sought to analyze indications, modality and outcomes of PS-ECLS, to identify predictors of early and midterm survival after PS-ECLS. The investigators have recorded prospectively, and analysed data of 209 consecutive PS-ECLS patients between January 2004 and December 2018. Demographic and clinical data before, during and after PS-ECLS were collected and their influence on hospital mortality and outcomes (early and midterm) will analyse. Multivariate analysis of pre PS-ECLS implantation factors (as age, female sex , insulin-dependent diabetes, pulmonary hypertension, STS, type of surgical procedure data, pre-ECLS blood lactate level) will be made for identify prognostic risk factors of in-hospital mortality. Overall survival will be analysed, at 6 months,1-year and 5-years, respectively and the factors influencing mild/term outcome will be investigated.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
500
Inclusion Criteria
  • Patients underwent cardiac surgery
Exclusion Criteria
  • Age < 18 years

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
SurvivalAt 5 years after surgery

late survival

Secondary Outcome Measures
NameTimeMethod
Prognostic FactorsLate: 5 years after surgery

Identify early and late negative and positive prognostic factors

Prognostic factorsEarly: 1 month after surgery

Identify early and late negative and positive prognostic factors

Trial Locations

Locations (1)

Massimo Bonacchi

🇮🇹

Florence, Italy

© Copyright 2025. All Rights Reserved by MedPath